FAF
RVMD icon

Fjarde Ap-fonden’s Revolution Medicines RVMD Stock Holding History

Fjarde Ap-fonden’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.5M Buy
56,300
+9,400
+20% +$1.37M 0.05% 295
2026
Q1 		$4.56M Buy
+46,900
New +$4.74M 0.02% 441

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Fjarde Ap-fonden's RVMD Position: Q2 2026 in Review

Fjarde Ap-fonden increased its Revolution Medicines (RVMD) stake by 20% in Q2 2026, buying an estimated $1.37M and bringing the position to 56,300 shares worth $10.5M. The position accounts for 0.05% of the portfolio, ranked #295.

Fjarde Ap-fonden first reported a position in RVMD in Q1 2026 and has held it in 2 quarters since. 693 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Fjarde Ap-fonden held 56,300 shares of Revolution Medicines worth $10.5M as of Q2 2026.
  • Fjarde Ap-fonden bought 9,400 Revolution Medicines shares in Q2 2026, an estimated $1.37M.
  • Revolution Medicines made up 0.05% of Fjarde Ap-fonden's portfolio in Q2 2026, its #295 holding.
  • Fjarde Ap-fonden first reported a position in Revolution Medicines in Q1 2026 and has held it in 2 quarters since.
  • 693 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Fjarde Ap-fonden's 13F filing for Q2 2026, filed 29 Jul 2026.